cancer Letters 75 (IYY.3) 207-20x

Subject index

Volume 75

CANCER LETTERS

Activated lymphocyte. progesterone. interleukin 2. 157

Apoptosis. monoclonal antibody. leukemia cells. metabolism,

microcalorimetry. 103

Aromatase. breast cancer. tobacco alkaloid. mhtbitor. estrogen

biosynthesis. I75

Azoxymethane. wheat bran fiber. psyllium fiber. 53

Bladder cancer. schistosomiasts, hycanthone. metrifonate. ox-

aminiquine. DNA methylation damage. DNA repair. 167

Bladder carcinoma. cytokeratm, differential expression. 87

Breast cancer, aromatase. tobacco alkaloid. inhibitor. estrogen

biosynthesis. 175

Breast cancer. fatty acids. invasion, 137

Breast cancer. HER-~!wu. ~1x5, steroid receptors. cathepsin

D. I95

Breast carcinoma. FSH, tibrocystic diseases. I

c-nzw. rat colon carcinogencsis. cell proltferation. magnesium

hydroxide. methylazoxymethanol acetate. 73

C3 activation products. ricin A chain. ricin

B chain. terminal SC56-9 complement complex. 59

cadmium, lung. cancer. metallothionein. copper. 121

Cancer, HT-29-1~4 cells. suramtn. polarity. lysosomal disorder.

quantitative autoradiography. 151

Cancer. lung, metallothionein. copper, cadmium. 121

Capsaicin. cytochrome P450. metabolism. I\jNK. 45

Carcinogenesis, inositol hexaphosphate, Sprague-Davvley rats.

pilot study. 95

Carcinogenic potency. rodents. humans. dose level limit. IX.7

Cathepsin D, breast cancer. HER-2/netr, ~1x5. steroid rrcep-

tars, 195

Cell proliferation. c-)rt~c. rat colon carcinogenesis. magnesium

hydroxide, methylazoxymethanol acetate. 7?

Ciaplatin. small cell lung cancer. drug resistance. glutathtonc.

glutathione S-transferase. I I I Combination therapy, tumor-induced angiogencsis. retinoids.

vitamin D?. 35

Copper. lung. cancer. metallol hionein, cadmium. 121

Cytochrome P450. capsaicin. metabolism. NNK. 45

Cytokeratin. bladder carcinoma. differential expression. X7

Differential expression. bladder carcinoma. cytokeratin, X7

Differentiation marker. HER-2inru. esophageal adenocarcino-

ma, 41

DNA 5-methylcytosine. mouse liver tumor. Ho-rus. methyla-

tion. oncogene, 129

DNA alkyltransferase. estrous cycle, Oh-methylguanine-DNA-

methyltransferase. I I

DNA methylation damage. schistosomiasis, hycanthone.

metrifonate. oxamintquine. bladder cancer. DNA repair,

167

DNA repair. schistosomiasis. hycanthone, metrifonate. ox-

aminiqume. bladder cancer. DNA methylation damage. 167

Dominant negative mutation. MS oncogene. tumor suppres-

sion. I9

Dose level limit. carcinogenic potency. rodents. humans, IX3

Drug resistance. cisplatin, small cell lung cancer, glutathione.

glutathione Stransferase. I I I

Esophagea! adenocarcinoma. HER-2fnc~. differentiation marker. 41

Estrogen biosynthesis. aromatase, breast cancer. tobacco alka-

loid. inhibitor. 175

Estrous cycle. Oh-methylguanine-DNA-methyltransferase.

DNA alkyltransferase, I I

Fatty acids. breast cancer. invasion. 137

Fibrocystic diseases. FSH. breast carcinoma. I 5-Fluorouracil.

renal cell cancer. lymphokine-activated killer cell. 27

FSH. breast carcinoma, Jibrocystic diseases. 1

Glutathione. cisplatin. small cell lung cancer. drug resistance.

glutathione S-transferasc. I I I Glutathione S-transferase. cisplatin. small cell lung cancer.

drug resistance. glutathione. I I I

Htr-ru,s. mouse liver tumor. methylation, DNA 5.

methylcytosrnc. oncogene. I29

Hematoporphyrms. photodynamic therapy. intrav,csical instil-

latton. 65

HER-21~u. differentiation marker. esophageal adenocarcino-

ma. 41

308

HER-Zinru. breast cancer. ~185. steroid receptors, cathepsin D.

195

HT-29-D4 cells. cancer. suramin. polarity. lysosomal disoder.

quantitative autoradiography, I51 Human colorectal tumor. a2.6-sialyltransferase. metastasis.

serum determinations, tumor monitoring. 143

Humans, carcinogenic potency, rodents. dose level limit. IX3

Hycanthone. schistosomiasis. metrifonate, oxaminiquinc, blad-

der cancer. DNA methylation damage. DNA repair. 167

Inhibitor. aromatase, breast cancer, tobacco alkaloid, estrogen

biosynthesis. I75

lnositol hexaphosphate. carcinogenesis. Sprague-Dawley rats.

pilot study. 95

lnterleukin 2. progesterone, activated lymphocyte. I57

lntravesical instillation. photodynamic therapy, hematopor-

phyrins. 65

Invasion, breast cancer, fatty acids, 137

Leukemia cells. monoclonal antibody. apoptosis. metabolism.

microcalorimetry, 103

Lung, cancer. metallothionein. copper, cadmium, 121

Lung cancer. vasopressin. oxytocin, neurophysin. 79

Lymphokine-activated killer cell. 5-fluorouracil. renal cell

cancer. 27

Lysosomal disorder. HT-29-D4 cells. cancer. suramin, polarity.

quantitative autoradiography. I51

Magnesium hydroxide. c-mrc, rat colon carcinogenesis. cell

proliferation, methylazoxymethanol acetate, 73

Metabolism, capsaicin. cytochrome P450. NNK. 45

Metabolism. monoclonal antibody, apoptosis. leukemia cells.

microcalorimetry, 103

Metallotionein. lung. cancer. copper, cadmium. I21

Metastasis. ol2.6~sialyltransferase, human colorectal tumor.

serum determinations. tumor monitoring, 143

Methylation. mouse liver tumor, Wtr-rcls, DNA 5-methyl-

cytosine, oncogene. 129

Methylazoxymethanol acetate, c-mrc, rat colon carcinogenesia.

cell proliferation. magnesium hydroxide. 73

Metrifonate. schistosomiasis. hycanthone. oxaminiquine. blad- der cancer, DNA methylation damage. DNA repair. 167

Microcalorimetry. monoclonal antibody, apoptosis. leukemia

cells. metabolism. 103

Monoclonal antibody. apoptosis. leukemia cells. metabolism.

microcalorimetry. 103

Mouse liver tumor, Ilo-FU.V. methylation. DNA 5-methyl-

cytosine. oncogene. I39

Neurophysin. vasopressin, oxytocin, lung cancer. 79

NNK. capsaicin. cytochrome P450. metabolism, 45

Oh-methylguanine-DNA-methyltransferase. estrous cycle.

DNA alkyftrdnsferase. I I

Oncogene. mouse liver tumor, Ho-rtrs. methylation, DNA 5- methylcytosine, 129

Oxaminiquine. schistosomiasis. hycanthone, metrifonate. blad-

der cancer. DNA methylation damage. DNA repair. 167

Oxytocin. vasopressin. neurophysin. lung cancer. 79

~185, breast cancer, HER-2ineu. steroid receptors. cathepsin D. I95

Photodynamic therapy. hematoporphyrins. intravesical instil-

lation, 65 Pilot study. carcinogenesis. inositol hexaphosphate.

Sprague-Dawley rats, 95

Polarity. HT-29-D4 cells. cancer. suramin, lysosomal disorder.

quantitattve autoradiography, 151

Progesterone, interleukin 2. activated lymphocyte. 157

Psyilium fiber. azoxymethane, wheat bran fiber, 53

Quantitative autoradiography, HT-29-D4 cells. cancer, suramin, polarity, lysosomal disorder. I51

US oncogene, dominant negative mutation. tumor suppression,

I9

Rat colon carcinogenesis. c-myc. cell proliferation. magnesium

hydroxide. methylazoxymethanol acetate. 73

Renal cell cancer, 5-fluorouracil. lymphokine-activated killer

cell, 27

Retinoids, tumor-induced angiogenesis, vitamin D,. combina-

tion therapy. 35

Ricin A chain, ricin B chain. C3 activation products. terminal

SC56-9 complement complex, S9

Ricin B chain, ricin A chain. C3 activation products. terminal

X56-9 complement complex, 59

Rodents. carcinogenic potency. humans, dose level limit, I83

Schistosomiasis, hycanthone, metrifonate. oxaminiquine, blad-

der cancer. DNA methylation damage. DNA repair. 167

Serum determinations. a2,6+ialyltransferase, human colorectal

tumor. metastasis, tumor monitoring, 143

cr2.6-sialyltransferase, human colorectal tumor. metastasis,

serum determinations. tumor monitoring, 143

Small cell lung cancer. cisplatin. drug resistance. glutathione.

glutathione S-transferase. I I I

Sprague-Dawfey rats. carcinogenesis. inositol hexaphosphate.

pilot study. 95

Steroid receptors. breast cancer. HER-2lne~. ~185. cathepsin D. 19.5

Suramin. HT-29-D4 cells. cancer. polarity. lysosomal disorder.

quantitative autoradiography. 151

Terminal SC56-9 complement complex. ricin A chain, ricin B

chain, C3 activation products. 59

Tobacco alkaloid, aromatase, breast cancer. inhrbitor,estrogen

biosynthesis. I75

Tumor monitoring, o2.6-sialyltransferase. human colorectal

tumor. metastasis. serum determinations. I43 Tumor suppression. dominant negative mutation. rt1.j onco-

gene, 19

Tumor-induced angiogenesis. retinoids. vitamin D?, combina-

tion therapy. 35

Vasopressin. oxytocin. neurophysin. lung cancer. 79

Vitamin D+ tumor-induced angiogenesis. retinoids. combina- tion therapy. 35

Wheat bran fiber. azoxymethane. psyllium fiber. 53